HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
Pricing decisions and access to pharmaceuticals should be evidence based. Unfortunately, the French guidelines for technology assessment, in their adoption of the National Institute for Health and Clinical Excellence (NICE) reference case modeling standard ensure that this is not the case. Rather t...
Main Author: | Paul C Langley |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2017-01-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/488 |
Similar Items
-
Sunlit Uplands: The Genius of the NICE Reference Case
by: Paul C Langley
Published: (2016-07-01) -
Imaginary Worlds and Efficiency Frontiers: Should We Abandon the IQWiG Health Technology Assessment Model?
by: Paul C Langley
Published: (2017-02-01) -
True North: Building Imaginary Worlds with the Revised Canadian (CADTH) Guidelines for Health Technology Assessment
by: Paul C Langley
Published: (2017-05-01) -
Guidelines for the prevention of surgical site infection: an update from NICE
by: David Leaper, et al.
Published: (2019-12-01) -
Intelligent Design and Imaginary Worlds in Cost-Effectiveness Claims: An Overview of Commentaries in INNOVATIONS in Pharmacy from July 2016 to February 2017
by: Paul C Langley
Published: (2017-03-01)